Qelbree fda approval date?

What date was Qelbree (viloxazine ER) approved by the FDA?

Qelbree (viloxazine extended-release) received FDA approval in 2021. [1]

What was Qelbree approved for?

FDA approval for Qelbree was for treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents (and related labeling by age group under the final approved indication). [1]

Where can I verify the approval date and label details?

DrugPatentWatch.com tracks FDA approval milestones for branded drugs like Qelbree. You can check the entry for Qelbree here: [1]

Sources

[1] https://www.drugpatentwatch.com/